Can Hims & Hers Health stock hold $27.08 support as sellers keep control?

Traders Union
All News
Stocks
Hims & Hers Health drops 8.91% today

Highlights

Shares of Hims & Hers Health fell 8.91% to $28.84, slipping below short- and medium-term moving averages intraday.
Downward momentum dominates with negative signals from oscillators and strong seller control, as the stock remains above long-term technical support.
Expected trading range over the next 2 to 3 days is $27.08 to $30.60, with a 67% probability of further downside.

Oversold readings signal caution as sellers dominate momentum

On the technical side, HIMS is trading below its MA-20 ($30.03) and MA-50 ($31.28) on the hourly chart, while remaining above the MA-200 ($28.61) on the daily timeframe. The Ichimoku Kijun at $30.52 acts as immediate resistance. Momentum indicators are largely negative: MACD remains in Sell mode, and ADX signals a neutral trend. RSI at 36.15, alongside CCI and Stochastic RSI, denotes oversold conditions and warrants caution regarding further downside, while Bull/Bear Power reflects strong seller dominance. The Awesome Oscillator also aligns with current downward momentum.

Sideways movement expected as volatility clouds bearish risk

Over the next 2–3 trading days, HIMS is expected to consolidate between $27.08 and $30.60, with a 67% probability of further downside and only a 33% chance of a rebound. Most likely, price will move sideways within this volatility band. A move above $30.60 would signal a shift in sentiment, while a breakdown below $27.08 would confirm further bearish momentum.

Viktoras Karapetjanc, expert at Traders Union, sees a consolidation phase developing for HIMS as price stabilizes below key moving averages. Despite clear technical signals of short-term weakness and strong seller dominance, he maintains a positive longer-term stance. The analyst believes that current oversold readings could limit further downside and eventually attract renewed buying interest. Karapetjanc maintains a constructive outlook while acknowledging caution is warranted. "Even as momentum turns negative, I see this as a potential opportunity for patient bulls willing to monitor $27.08 as key support."

Earlier, analysts noted that Hims & Hers Health was experiencing short-term technical weakness despite fundamentally positive developments. The latest price action strengthens this view, as downside momentum and oversold indicators suggest traders should monitor for a potential test of support or heightened volatility in the days ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.